Ringwood-based liver charity slams ruling
A RINGWOOD-based charity has attacked the decision not to allow NHS patients a last hope drug for treating liver cancer. The National Institute for Health and Clinical Excellence (NICE) found that sorafenib, sold under the trade name of Nexavar, was